Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older.

The Centers for Disease Control and Prevention reports the latest Omicron subvariants KP.1, KP.2, and KP.3, had accounted for most cases by the first week of August. KP.1 and KP.2 are members of a ...

For those wanting the home test kit, free rapid antigen tests will continue to be available through local public health units ...

The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...

Health Canada has told the provinces to pull existing supplies of the COVID-19 vaccine that targets the XBB form of Omicron, a spokesperson for Ontario's health minister says. "Health Canada has ...

2 variant – a member of the omicron family that rose to prominence over the summer. The Novavax vaccine, which is based on an older technology, targets an earlier strain of the virus called JN.1 ...

Invivyd Inc. beat a shareholder lawsuit alleging the biopharma company misled shareholders with optimistic projections about the effectiveness of its Covid-19 treatment against the omicron variant.